HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias Kotzsch Selected Research

Tissue Extracts

1/2017Inverse association of rab31 and mucin-1 (CA15-3) antigen levels in estrogen receptor-positive (ER+) breast cancer tissues with clinicopathological parameters and patients' prognosis.
1/2016Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome.
12/2014Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis.
1/2014Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer.
4/2010Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.
4/2003Tissue specific expression and serum levels of human tissue factor in patients with urological cancer.
3/2003Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthias Kotzsch Research Topics

Disease

37Neoplasms (Cancer)
12/2021 - 03/2003
13Breast Neoplasms (Breast Cancer)
12/2021 - 04/2003
12Ovarian Neoplasms (Ovarian Cancer)
07/2019 - 06/2009
8Urinary Bladder Neoplasms (Bladder Cancer)
07/2008 - 04/2003
6Neoplasm Metastasis (Metastasis)
12/2014 - 04/2003
6Sarcoma (Soft Tissue Sarcoma)
06/2013 - 03/2003
5Residual Neoplasm
07/2019 - 12/2016
2Ascites
07/2019 - 01/2019
2Carcinogenesis
01/2017 - 09/2003
2Prostatic Neoplasms (Prostate Cancer)
01/2014 - 04/2010
1Renal Cell Carcinoma (Grawitz Tumor)
12/2014
1Head and Neck Neoplasms (Head and Neck Cancer)
09/2010
1Hypoxia (Hypoxemia)
04/2010
1Myocardial Infarction
11/2007
1Heart Failure
11/2007
1Hypertrophy
11/2007
1Infarction (Infarctions)
11/2007
1Ischemia
11/2007
1Transitional Cell Carcinoma
11/2004
1Acute Lung Injury
07/2004
1Urologic Neoplasms (Urological Cancer)
04/2003
1Thrombosis (Thrombus)
03/2003

Drug/Important Bio-Agent (IBA)

23Messenger RNA (mRNA)IBA
12/2021 - 04/2003
16Proteins (Proteins, Gene)FDA Link
07/2019 - 03/2003
11Peptide Hydrolases (Proteases)FDA Link
07/2019 - 11/2005
8Kallikreins (Kallikrein)IBA
07/2019 - 04/2010
8Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2014 - 04/2003
7Tissue ExtractsIBA
01/2017 - 03/2003
6AntigensIBA
01/2017 - 02/2008
5Small Interfering RNA (siRNA)IBA
09/2010 - 03/2004
5SurvivinIBA
02/2006 - 03/2003
4Serine Proteases (Serine Protease)IBA
06/2018 - 06/2006
4Plasminogen Activator Inhibitor 1IBA
12/2014 - 02/2008
4OligodeoxyribonucleotidesIBA
02/2006 - 09/2003
3Biomarkers (Surrogate Marker)IBA
10/2018 - 01/2017
3Extracellular Matrix ProteinsIBA
08/2012 - 02/2008
3OsteopontinIBA
04/2012 - 04/2010
3Urokinase Plasminogen Activator ReceptorsIBA
06/2011 - 11/2005
3Thromboplastin (Tissue Factor)IBA
11/2007 - 03/2003
2Biological ProductsIBA
12/2021 - 06/2009
2Indicators and Reagents (Reagents)IBA
07/2019 - 01/2019
2Tissue Kallikreins (Tissue Kallikrein)IBA
10/2018 - 06/2006
2Estrogen ReceptorsIBA
01/2017 - 08/2012
2Tumor Biomarkers (Tumor Markers)IBA
01/2017 - 06/2013
2RNA (Ribonucleic Acid)IBA
01/2014 - 09/2008
2matrigelIBA
08/2012 - 06/2011
2GemcitabineFDA Link
07/2005 - 11/2004
2Mitomycin (Mitomycin-C)FDA LinkGeneric
07/2005 - 11/2004
2Cisplatin (Platino)FDA LinkGeneric
07/2005 - 11/2004
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2004 - 09/2003
1GTP-Binding Proteins (G-Protein)IBA
12/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021
1Detergents (Detergent)IBA
01/2017
1AngiostatinsIBA
01/2017
1estropipate (Ogen)FDA LinkGeneric
01/2017
1Mucin-1 (CA 15-3 Antigen)IBA
01/2017
1FibrinolysinFDA Link
01/2017
1Monomeric GTP-Binding ProteinsIBA
01/2017
1rat KLK7 proteinIBA
01/2014
1Histone Deacetylase InhibitorsIBA
01/2013
1High-Temperature Requirement A Serine Peptidase 1IBA
01/2013
1Biological FactorsIBA
11/2011
1Plasminogen Activators (Plasminogen Activator)IBA
06/2011
1AntibodiesIBA
04/2010
1VitronectinIBA
06/2009
1IntegrinsIBA
06/2009
1TetraspaninsIBA
06/2009
1LigandsIBA
06/2009
1Integrin alphaVbeta3IBA
06/2009
1Plasminogen InactivatorsIBA
02/2008
1ThrombinFDA Link
11/2007
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
06/2006
1Tissue Inhibitor of Metalloproteinase-3IBA
11/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2005
1FluorocarbonsIBA
07/2004
1ImmunosorbentsIBA
04/2003
1EnzymesIBA
04/2003

Therapy/Procedure

6Therapeutics
09/2008 - 06/2004
4Drug Therapy (Chemotherapy)
12/2016 - 11/2004
2Radiotherapy
04/2012 - 09/2010
1Nephrectomy
12/2014
1Aftercare (After-Treatment)
03/2004